ICD-10-CM Billable Code

H02.719

Chloasma of unspecified eye, unspecified eyelid and periocular area

Clinical Classification Guidelines

Medical Intelligence & Overview

Chloasma, also known as melasma or hyperpigmentation, is a common skin condition characterized by dark, discolored patches on the skin. When it appears around the eyes, eyelids, or periocular area, it can affect the appearance and sometimes cause cosmetic concerns. ICD-10 code H02.719 specifically refers to chloasma of unspecified eye, eyelid, and periocular region. While often harmless, understanding this condition can help individuals recognize symptoms and learn about potential causes and management options.

Causes & Symptoms

Clinical Causes: Excessive exposure to sunlight or UV rays, which stimulates melanin production Hormonal changes, such as those during pregnancy, using birth control pills, or hormone replacement therapy Genetic predisposition, with a tendency to develop pigmentation irregularities Use of certain skincare products that may irritate the skin or cause pigmentation changes Underlying medical conditions affecting hormonal balance or skin health

Key Symptoms: Asymptomatic dark patches or spots on or around the eyelids and periocular area Symmetrical discoloration but sometimes irregular in shape Color varies from light brown to darker brown, depending on pigmentation No pain, swelling, or other physical discomfort often associated Gradual appearance over weeks or months, possibly worsened by sun exposure

Diagnostic & Treatment

Diagnosis Path: Diagnosis of chloasma in the periocular region typically involves a clinical examination by a healthcare professional. The provider will evaluate the appearance, distribution, and color of the pigmented patches. They may also review medical history, hormonal factors, and exposure to sunlight. In some cases, additional tests such as dermoscopy or skin biopsy may be performed to rule out other skin conditions or hyperpigmentation disorders. No laboratory tests are generally required solely for diagnosing this condition.

Treatment Protocols: Management of chloasma focuses on minimizing its appearance and preventing further pigmentation. Approaches may include: - Sun protection: Regular use of broad-spectrum sunscreens and physical barriers like sunglasses and hats to reduce UV exposure - Topical treatments: Ingredients like hydroquinone, tretinoin, corticosteroids, or Azelaic acid, which can lighten hyperpigmented areas - Chemical peels: Superficial chemical peels performed by dermatologists may help improve appearance - Laser therapy: Laser treatments are sometimes used for stubborn cases, but should be considered carefully due to potential risks - Hormonal regulation: Addressing any hormonal imbalances or changing medications if appropriate It is important to note that treatment results can vary, and some pigmentation may remain even with therapy. Prevention of sun exposure remains a key component in managing chloasma.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H02.719 a billable ICD-10 code?
Yes, H02.719 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H02.719?
Clinical documentation must specify the nature of Chloasma of unspecified eye, unspecified eyelid and periocular area and any associated comorbidities for accurate reporting.

Cite this Clinical Reference